Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans for the first time, finding it to ...

Based on current surveillance indicators, influenza, COVID-19 and RSV activity is classified as low in North Dakota. The current respiratory disease surveillance data for North Dakota, released by the ...

A runny nose may indicate you have COVID-19, but it can also stem from a cold or allergies. Here’s how to know what’s causing ...

A Cambridge-led team has developed an early-stage vaccine platform that uses computational design to ...

The health director of Ginoogaming First Nation is hoping everyone in the community will be tested for COVID-19 soon, after more nursing support led to an increase in testing capacity. Ginoogaming ...

The U.S. FDA has approved ensitrelvir (Xocova), an oral antiviral developed by Shionogi, to help prevent COVID-19 in ...

Shionogi Announces FDA Approval of XOCOVA®, the First and Only Oral Option to Help Prevent COVID-19 Following Exposure ...

In the highest annual total in the history of the statute, the Department of Justice’s False Claims Act settlements and judgments exceeded $6.8 billion in fiscal year 2025, with more than $5.7 billion ...

FDA approves ensitrelvir for COVID-19 postexposure prophylaxis following phase 3 data showing efficacy against Omicron symptoms. The FDA recently approved ensitrelvir (Xocova; Shionogi), an ...

While the pandemic may be over, its enduring effects are being felt by millions. While most people who test positive for ...

Another two million free rapid testing kits are now being offered to public, private and not-for-profit employers and service providers, the Alberta government said Tuesday in a news release. The ...

The 2026 epidemic of Ebola virus disease caused by Bundibugyo virus (species Orthoebolavirus bundibugyoense) in DR Congo and Uganda has been declared a public health emergency of international concern ...